On your first point, I seem to remember last year, I think with...

On your first point, I seem to remember last year, I think with either 2101 or 0201 the data was ‘Embargoed’ for a presentation. Rings a bell only because of that word. If that’s the case and they’ve got a spot at ASCO with a global spotlight…. Well it’s not a long bow to assume what that could possibly mean.
But I get your point, this is my only Hopper company so I’m not totally aware of how he operates. If any one cares, I found chimeric by coincidence a couple of days before ipo and read up on some stuff about chlorotoxin and when I saw they were already in a phase one I figured it was a no brainer to jump in and see how’s things went. No bad news and 2 additional assets later (if you’re only counting the ones in clinic or soon to be) and here we are. Still buying when I can but if people spent time researching and understanding the significance of what chimeric are doing in terms or treating solid cancer they’d understand that there are multiple bags to be made here.

Totally agree re names. It’s confusing AF.